Last Updated : September 5, 2023
Details
Generic Name:
NovoTTF-200A
Project Status:
Active
Therapeutic Area:
Supratentorial glioblastoma (GBM)
Manufacturer:
Novocure Canada Inc.
Call for patient/clinician input open:
Brand Name:
Optune
Project Line:
Health Technology Review
Project Sub Line:
Optimal Use
Project Number:
OP0554-000
Call for patient/clinician input closed:
To enhance the quality and relevance of this work, CADTH is engaging people with extensive personal and/or professional experience within the Canadian health system.
CADTH Call for Statements of Interest
End of feedback period: January, 2024
| Call for patient/clinician input open | July 13, 2023 |
|---|---|
| Call for patient/clinician input closed | September 1, 2023 |
| Submission received | August 18, 2023 |
| Submission accepted | September 1, 2023 |
| Review initiated | September 5, 2023 |
| Draft CADTH review report(s) provided to sponsor for comment | |
| Deadline for sponsors comments | |
| CADTH review report(s) and responses to comments provided to sponsor | |
| Expert committee meeting (initial) | |
| Draft recommendation issued to sponsor | |
| Draft recommendation posted for stakeholder feedback | |
| End of feedback period |
Last Updated : September 5, 2023
